Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
12 Dec 2019
Osteoporosis patients believe their condition is neglected and deprioritised by healthcare authorities
Read More
12 Dec 2019
European Commission Approves EVENITY[®] (Romosozumab) for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture
Read More
10 Dec 2019
UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting
Read More
6 Dec 2019
Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira[®]
Read More
15 Nov 2019
Bimekizumab Positive Results Confirmed in Second Phase 3 Psoriasis Study
Read More
8 Nov 2019
Transparency notifications BlackRock, Inc.
Read More
8 Nov 2019
UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs in Axial Spondyloarthritis, Psoriatic Arthritis and Lupus at 2019 ACR/ARP
Read More
18 Oct 2019
Transparency notification Vanguard Health Care Fund
Read More
18 Oct 2019
EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture
Read More
17 Oct 2019
Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
16
Page
17
Page
18
Page
19
Current page
20
Page
21
Page
22
Page
23
Page
24
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss